198例药物性肝病的临床分析  

作　　者：李光[1] 谢玉兰[1] 

机构地区：[1]焦作市人民医院,河南焦作454002

出　　处：《现代保健（医学创新研究）》2007年第02X期7-8,共2页

摘　　要：目的探讨药物性肝病的病因、临床特点、治疗效果及预后。方法本文对198例药物性肝病患者就诊时的肝功能、症状、体症进行分析。结果经过治疗本组DILD治愈或好转91．41％，无好转7．58％，死亡率为1．01％。结论此类患者除及时停药保肝药物治疗外，同时也提醒临床医生在抗结核及抗肿瘤治疗前应常规检查肝功能，尽量选用对肝脏损害小的药物，减少药物性肝病的发生。Objective To study etiopathogenisis, clinical characteristic, therapeutic efficacy and prognosis of drug - induced liver disease. Method To analyze body sign , symptom and Hepatic function in 198 cases. Result The rate of curing or improving is 91.41% , the rate of inefficacy is 7.58% , the death rate is 1.01% . Conclusion The drug of damaging liver should be promptly discontinuation and liver protectant should be utilize, meanwhile , we should adopt drug of no - damaging liver and decrease rate of drug - induced liver disease in antituberculosis or antineoplaston .

关 键 词：药物性肝病 预后 分析 

分 类 号：R575[医药卫生—消化系统]